Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 32579 | 32579 | 31109 |
PDF Downloads | 119 | 119 | 30 |
Escherichia coli (E. coli) is a commensal organism in humans and animals. It can serve as a reservoir for antibiotic resistance, thus providing an indicator of drug resistance patterns in a community. We investigated antibiotic resistance in E. coli isolated from nondiarrheal stool samples of 6-month-old infants (n = 110) from northwest Bangladesh. We conducted susceptibility testing using a disc diffusion assay against 20 antibiotics. Resistance was most pronounced for macrolides (98.2% resistant), whereas the most sensitive antibiotics were fosfomycin (100%), gentamicin (99.1%), meropenem (98.2%), mecillinam (97.3%), tigecycline (97.3%), and imipenem (87.3%). Excluding erythromycin, roughly 55% of isolates were multidrug-resistant. Our results likely reflect the burden of drug-resistant E. coli in the guts of infants in rural Bangladesh and the prevailing drug resistance patterns in this community.
Financial support: This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [OPP1163259]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission.
Disclosure: This study was approved by the Institutional Review Board at the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD) and the Research and Ethics Review Committees at the International Centre for Diarrheal Disease Research, Bangladesh.
Current contact information: Fatema-Tuz Johura, Subhra Chakraborty, and Alain Labrique, Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, E-mails: mjohura1@jh.edu, schakr11@jhu.edu, and alabriqu@gmail.com. Jarin Tasnim, Tahmeed Ahmed, Md Iqbal Hossain, and Munirul Alam, International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh, E-mails: jarintasnim537@gmail.com, tahmeed@icddrb.org, ihossain@icddrb.org, and munirul@icddrb.org. Sahitya Ranjan Biswas, Translational Biology, Medicine, and Health Graduate Program, Virginia Polytechnic Institute and State University, Roanoke, VA, E-mail: ayanranjanbiswas25@gmail.com. Riajul Islam, IT and Public Service Audit Directorate, Dhaka, Bangladesh, E-mail: riaj1991@gmail.com. Talal Hossain, Wellcome Trust Genome Campus, Hinxton, Saffron Walden, United Kingdom, E-mail: th14@sanger.ac.uk. Hafizur Rahman, The JiVitA Research Project, Bangladesh, Rangpur, Bangladesh, E-mail: hafiz.jivita@gmail.com. Saijuddin Shaikh, Centre for Health Research and Development, Society for Applied Studies, New Delhi, India, E-mail: saijuddin.shaikh@sas.org.in. Hasmot Ali, The JiVitA Research Project, Bangladesh, Rangpur, Bangladesh, E-mail: hasmot.jivita@gmail.com. Amanda C. Palmer, Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, E-mail: acpalmer@jhu.edu.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 32579 | 32579 | 31109 |
PDF Downloads | 119 | 119 | 30 |